Inhibition of H-Ras and MAPK is compensated by PKC-dependent pathways in annexin A6 expressing cells

Carles Rentero1, Rachael Evans, Peta Wood

  • 1Departament de Biologia Cellular, Facultat de Medicina, Universitat de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain, and Centre for Immunology, St. Vincent's Hospital, Sydney, NSW, Australia.

Cellular Signalling
|September 27, 2005
PubMed

Insights

High-density lipoprotein (HDL) activates the Ras/MAPK pathway. In cells expressing annexin A6, HDL-induced H-Ras and MAPK activation becomes protein kinase C (PKC)-dependent, compensating for reduced PKC-independent pathways.

Area of Science:

  • Cellular signaling pathways
  • Lipid metabolism and cell communication

Background:

  • High-density lipoprotein (HDL) signaling involves the Ras/MAPK pathway, mediated by both protein kinase C (PKC)-dependent and independent mechanisms.
  • HDL binding to scavenger receptor BI (SR-BI) in Chinese hamster ovary (CHO) cells typically activates Ras and MAPK via a PKC-independent route.
  • Annexin A6 expression in CHO cells (CHOanx6) reduces HDL-induced Ras and Raf-1 activation.

Purpose of the Study:

  • To investigate the role of protein kinase C (PKC) in HDL-induced Ras and MAPK activation in annexin A6-expressing CHO cells (CHOanx6).
  • To elucidate the compensatory mechanisms for reduced PKC-independent signaling in CHOanx6 cells.

Main Methods:

  • Utilized CHO and CHOanx6 cell lines.
  • Investigated HDL-induced activation of the Ras/MAPK pathway.
  • Assessed the involvement of PKCalpha in HDL signaling.

Main Results:

  • HDL binding to SR-BI in CHO cells activates Ras and MAPK independently of PKC.
  • HDL-induced Ras and Raf-1 activation is diminished in CHOanx6 cells.
  • Despite reduced Ras and Raf-1 activity, HDL still induces MAPK phosphorylation in CHOanx6 cells.
  • HDL-induced H-Ras and MAPK activation is PKC-dependent in CHOanx6 cells.

Conclusions:

  • Annexin A6 expression shifts HDL-induced H-Ras and MAPK activation towards a PKC-dependent pathway.
  • This PKC-dependent activation compensates for the loss of PKC-independent signaling in annexin A6-expressing cells.
  • The findings highlight a novel regulatory mechanism in HDL signaling involving annexin A6 and PKC.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...